BR9407145A - Métodos para tratar apoptose e condições associadas - Google Patents

Métodos para tratar apoptose e condições associadas

Info

Publication number
BR9407145A
BR9407145A BR9407145A BR9407145A BR9407145A BR 9407145 A BR9407145 A BR 9407145A BR 9407145 A BR9407145 A BR 9407145A BR 9407145 A BR9407145 A BR 9407145A BR 9407145 A BR9407145 A BR 9407145A
Authority
BR
Brazil
Prior art keywords
methods
associated conditions
treat apoptosis
apoptosis
treat
Prior art date
Application number
BR9407145A
Other languages
English (en)
Inventor
L David Tomei
Original Assignee
Lxr Biotechnologie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lxr Biotechnologie Inc filed Critical Lxr Biotechnologie Inc
Publication of BR9407145A publication Critical patent/BR9407145A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9407145A 1993-07-23 1994-07-22 Métodos para tratar apoptose e condições associadas BR9407145A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9678893A 1993-07-23 1993-07-23
PCT/US1994/008268 WO1995003054A1 (en) 1993-07-23 1994-07-22 Methods of treating apoptosis and associated conditions

Publications (1)

Publication Number Publication Date
BR9407145A true BR9407145A (pt) 1996-09-17

Family

ID=22259083

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9407145A BR9407145A (pt) 1993-07-23 1994-07-22 Métodos para tratar apoptose e condições associadas

Country Status (7)

Country Link
EP (1) EP0711168A4 (pt)
JP (1) JPH09503749A (pt)
KR (1) KR960703597A (pt)
AU (1) AU7370594A (pt)
BR (1) BR9407145A (pt)
CA (1) CA2167805A1 (pt)
WO (1) WO1995003054A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3866800B2 (ja) * 1996-08-29 2007-01-10 東菱薬品工業株式会社 アポトーシス関連疾患の予防及び／又は治療薬
US6693100B1 (en) 1999-09-10 2004-02-17 Iervant Zarmanian Pharmaceutical compositions for treating psoriasis
WO2001019358A2 (en) * 1999-09-10 2001-03-22 Cyathus Exquirere Pharmaforschungs Gmbh Use dexrazoxane for treating psoriasis
US6552025B1 (en) 1999-11-24 2003-04-22 Emory University Diimino-piperazine derivatives for use as modulators of cell regulation
AU5150200A (en) * 1999-11-24 2001-06-04 Emory University Diimino-piperazine derivatives for use as modulators of cell regulation
BR0112969A (pt) 2000-08-04 2004-06-22 Dmi Biosciences Inc Método de utilização de dicetopiperazinas e composições contendo-as
US7732403B2 (en) * 2003-05-15 2010-06-08 Dmi Biosciences, Inc. Treatment of T-cell mediated diseases
CA2529318C (en) * 2003-06-24 2013-09-17 University Of Connecticut Methods of inhibiting vascular permeability and apoptosis
GB0314733D0 (en) * 2003-06-24 2003-07-30 Glaxo Group Ltd Medicaments
WO2008021250A2 (en) * 2006-08-10 2008-02-21 Fred Hutchinson Cancer Research Center Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
CA2810844C (en) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
PL2766029T3 (pl) 2011-10-10 2020-08-24 Ampio Pharmaceuticals, Inc. Leczenie choroby zwyrodnieniowej stawów
WO2013055749A1 (en) 2011-10-10 2013-04-18 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
JP6231484B2 (ja) 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 鼻炎の処置
CN105101965B (zh) 2013-03-15 2021-03-09 安皮奥制药股份有限公司 用于干细胞活动化、归巢、扩增和分化的组合物及其使用方法
RU2736513C2 (ru) 2014-08-18 2020-11-17 Ампио Фармасьютикалз, Инк. Лечение патологических состояний суставов
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW MOLECULAR WEIGHT HUMAN SERUM ALBUMIN FRACTIONS FOR TREATING DISEASES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916072D0 (en) * 1989-07-13 1989-08-31 Creighton Andrew M Pharmaceutical compositions
GB9024861D0 (en) * 1990-11-15 1991-01-02 Hellmann Kurt Bis-dioxopiperazines for treating liver tumors

Also Published As

Publication number Publication date
CA2167805A1 (en) 1995-02-02
KR960703597A (ko) 1996-08-31
EP0711168A4 (en) 1998-04-01
WO1995003054A1 (en) 1995-02-02
AU7370594A (en) 1995-02-20
JPH09503749A (ja) 1997-04-15
EP0711168A1 (en) 1996-05-15

Similar Documents

Publication Publication Date Title
BR9407145A (pt) Métodos para tratar apoptose e condições associadas
BR9508886A (pt) Compostos e métodos para o tratamento de câncer
BR9206540A (pt) Processo e agente para renovação de água
BR9603431A (pt) Método para tratar privação de abuso de substância
FI960165A0 (fi) Säädetty apoptoosi
PT8866U (pt) Entressola aperfeicoada para calcado
FI951163A (fi) Jätteen käsittely
FI931577A (fi) Vattenringpumpar med foerbaettrade husformer
BR9403862A (pt) Banheira para hidromassagem
MX9101045A (es) Metodo para proveer efecto analgesico mejorado
UA10998C2 (uk) Спосіб поліфакторhої лікувальhої дії та ковдра для поліфакторhої лікувальhої дії
DK36193D0 (da) Fremgangsmaade
KR930023054U (ko) 맛사지기
KR940018945U (ko) 치질치료 및 예방용 좌욕조
KR940002718U (ko) 치질예방 및 치료기
BR9400216A (pt) Eletroseparador para descascadores
KR950005763U (ko) 용수처리기
BR9300701A (pt) Tratamento de água para consumo humano e outros fins
NO923108D0 (no) Hudpleie-behandling
LV10005A (lv) Udens apstradasanas panemiens
KR950006374U (ko) 용수처리기
BR7200343U (pt) Tarraxa para brincos
SE9300795D0 (sv) Ny princip foer smaertbehandling
KR950000472U (ko) 수압형 안마기
BR8800046A (pt) Processo e aparelho para tratamento de agua

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law